Annual long term liabilities:
$40.92M-$6.19M(-13.15%)Summary
- As of today (June 1, 2025), RNA annual total long term liabilities is $40.92 million, with the most recent change of -$6.19 million (-13.15%) on December 31, 2024.
- During the last 3 years, RNA annual long term liabilities has risen by +$24.43 million (+148.11%).
- RNA annual long term liabilities is now -73.09% below its all-time high of $152.03 million, reached on December 31, 2019.
Performance
RNA Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$45.49M+$4.57M(+11.17%)Summary
- As of today (June 1, 2025), RNA quarterly total long term liabilities is $45.49 million, with the most recent change of +$4.57 million (+11.17%) on March 31, 2025.
- Over the past year, RNA quarterly long term liabilities has dropped by -$133.00 thousand (-0.29%).
- RNA quarterly long term liabilities is now -70.08% below its all-time high of $152.03 million, reached on December 31, 2019.
Performance
RNA quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RNA Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.2% | -0.3% |
3 y3 years | +148.1% | +213.6% |
5 y5 years | -73.1% | +196.6% |
RNA Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.2% | +364.1% | -3.5% | +615.0% |
5 y | 5-year | -73.1% | +364.1% | -3.5% | +615.0% |
alltime | all time | -73.1% | +364.1% | -70.1% | +615.0% |
RNA Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $45.49M(+11.2%) |
Dec 2024 | $40.92M(-13.1%) | $40.92M(-11.2%) |
Sep 2024 | - | $46.06M(+9.2%) |
Jun 2024 | - | $42.18M(-7.5%) |
Mar 2024 | - | $45.62M(-3.2%) |
Dec 2023 | $47.11M(+434.3%) | $47.11M(+575.0%) |
Sep 2023 | - | $6.98M(+9.7%) |
Jun 2023 | - | $6.36M(-8.8%) |
Mar 2023 | - | $6.98M(-20.9%) |
Dec 2022 | $8.82M | $8.82M(-19.0%) |
Sep 2022 | - | $10.89M(-14.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $12.76M(-12.0%) |
Mar 2022 | - | $14.51M(-12.0%) |
Dec 2021 | $16.49M(+26.0%) | $16.49M(+91.3%) |
Sep 2021 | - | $8.62M(-11.2%) |
Jun 2021 | - | $9.71M(-12.7%) |
Mar 2021 | - | $11.12M(-15.0%) |
Dec 2020 | $13.09M(-91.4%) | $13.09M(+6.5%) |
Sep 2020 | - | $12.29M(-8.6%) |
Jun 2020 | - | $13.44M(-12.4%) |
Mar 2020 | - | $15.34M(-89.9%) |
Dec 2019 | $152.03M(+275.4%) | $152.03M |
Dec 2018 | $40.49M | - |
FAQ
- What is Avidity Biosciences annual total long term liabilities?
- What is the all time high annual long term liabilities for Avidity Biosciences?
- What is Avidity Biosciences annual long term liabilities year-on-year change?
- What is Avidity Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Avidity Biosciences?
- What is Avidity Biosciences quarterly long term liabilities year-on-year change?
What is Avidity Biosciences annual total long term liabilities?
The current annual long term liabilities of RNA is $40.92M
What is the all time high annual long term liabilities for Avidity Biosciences?
Avidity Biosciences all-time high annual total long term liabilities is $152.03M
What is Avidity Biosciences annual long term liabilities year-on-year change?
Over the past year, RNA annual total long term liabilities has changed by -$6.19M (-13.15%)
What is Avidity Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of RNA is $45.49M
What is the all time high quarterly long term liabilities for Avidity Biosciences?
Avidity Biosciences all-time high quarterly total long term liabilities is $152.03M
What is Avidity Biosciences quarterly long term liabilities year-on-year change?
Over the past year, RNA quarterly total long term liabilities has changed by -$133.00K (-0.29%)